Design Thinking for Patient Engagement

design thinking for patient engagement

Design thinking.  It's the "it" buzzword these days, but what does it mean for healthcare and patient engagement? Design thinking is human centered. Design thinking is synonymous with the firm IDEO, a global design consultancy.  Week three of Stanford's Patient Engagement class was "Design Thinking for Patient Engagement" lead by Dennis Boyle.  Mr. Boyle is a … Continue reading Design Thinking for Patient Engagement

Advertisements

What’s in it for me? Patient Engagement Healthcare Design

patient engagement design healthcare stakeholders adult learning

Stanford University's Anesthesia Informatics and Media (AIM) lab is doing seriously innovative, cool stuff with healthcare, including offering a Patient Engagement Healthcare Design Class this fall.  Today I'm sharing some of the key learnings from Week One, appropriately named, Introduction to Patient Engagement Design. Our lecture for week one was led by Kyra Bobinet, MD, … Continue reading What’s in it for me? Patient Engagement Healthcare Design

Free Access to Medicine X 2014!

Medicine X

That's right. You have an option to register for live, online access to a number of the sessions at Medicine X through Medicine X's Global Access Program, September 5-7th. It won't give you access to the breakouts, but you will get access to the conference plenary proceedings, live photos and other updates to your phone, tablet … Continue reading Free Access to Medicine X 2014!

Musings of an ex-pharma rep.

hope for big pharma

I'm hesitant to post this one.  Today many of my hardworking, dedicated former colleagues at Lilly will find out they no longer have a job.  I believe some of this could have been avoided. To Lilly's credit, it has made tremendous efforts to keep as many sales people as it could over the years while … Continue reading Musings of an ex-pharma rep.

Are you there, Pharma? It’s me, Liz. Part 3: making real change in 2013

Part 3: Making change happen in the pharmaceutical industry in 2013

Welcome to the final entry in my mini-series "Are you there, Pharma? It's me, Liz," about creativity squashers in the pharmaceutical industry. Part one included a short overview of the uncertainty this industry is facing and a decree for strategic integration of social strategies.  It also suggested that pharma must begin to, "Listen and Act." Part two … Continue reading Are you there, Pharma? It’s me, Liz. Part 3: making real change in 2013

Are you there Pharma? It’s me, Liz. Part two: What’s Killing Creativity in Big Pharma Sales Forces?

Big Pharma Business Model squashing creativity

Welcome back to the second post in my series, "Are you there Pharma? It's me, Liz."   This series identifies creative thinking squashers in Pharma and suggests strategic changes that will help Big Pharma to improve its business model, in hopes of radically changing the way Pharma goes about its business.  The first post discussed … Continue reading Are you there Pharma? It’s me, Liz. Part two: What’s Killing Creativity in Big Pharma Sales Forces?

Are you there, Pharma? It’s me, Liz. Part One: Listening and Acting

Are you there, Pharma? It's me, Liz.

As an ex-pharma veteran, I have experienced first hand, the challenges that Big Pharma faces as it struggles to figure out how to compete in a radically changing healthcare system.  This mini series focuses on some changes that I would love to see in the industry, and quite frankly, changes that are necessary if Pharma … Continue reading Are you there, Pharma? It’s me, Liz. Part One: Listening and Acting